March 7 (Reuters) - Imugene Ltd (IMU) :
- Manufacturing update
- Updates on manufacturing of its her-vaxx cancer immunotherapy product, currently initiating activity in gastric cancer
- Entire process of her-vaxx cancer immunotherapy product development has resulted in saving of > $500,000 to imugene's bottom line from original budget
News: IMU Imugene Ltd updates on cancer immunotherapy product development
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.045(10.6%) |
Mkt cap ! $81.26M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 34.5¢ | $1.196M | 3.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2058 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 53762 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |